This study investigates if electroencephalography (EEG) neurofeedback training is more beneficial than sham feedback training for the improvement of communication, anxiety, and sleep quality in individuals with aphasia. Half of the participants will receive active EEG neurofeedback sessions first, followed by sham feedback sessions in a crossover design. The other half of participants will undergo sham feedback sessions first, followed by active neurofeedback.
Neurofeedback, a form of biofeedback, provides a visual and/or audio representation of an individual's neural electrical activity from live EEG recording. Using operant conditioning principles, individuals are trained to increase or reduce patterns of brainwave activity to modify behavior and performance. Although neurofeedback has not yet been investigated as a treatment for aphasia or other communication deficits due to stroke or neurodegenerative disease, it may be effective. Previous studies have observed improvement in cognitive and behavioral measures in those with conditions such as Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder. Furthermore, it has been associated with reduced anxiety and sleep disruption, which both exacerbate language and communication impairments. Research is needed to determine if neurofeedback may be an effective treatment for language disorders such as PPA and post-stroke communication disorders. It is possible that EEG neurofeedback, which focuses on improving abnormal brainwave patterns, could provide certain therapeutic benefits to individuals with PPA or post-stroke aphasia, either by directly affecting neural networks that underlie language, or more generally by reducing anxiety and inattention through behavioral conditioning. Reduction of anxiety in neurological diseases can be beneficial not only for functional performance but also sleep duration and quality.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
Active EEG neurofeedback
Sham EEG feedback sessions identical to active sessions except that the feedback given to the participant will not be based on the individual's live EEG activity.
Johns Hopkins School of Medicine
Baltimore, Maryland, United States
Change in Number of Items Correctly Named on the Philadelphia Naming Test
Change in number of items correctly named on a behavioral picture naming assessment. The score range is 0 - 175 (higher scores reflect more accurate naming/better naming ability)
Time frame: Baseline, 1 week following each intervention period
Change in Controlled Oral Word Association Test (COWA) Score
This is a measure of attention, executive function, and word-retrieval. COWA scores range from 0 to infinity. Lower scores represent more language impairment.
Time frame: Baseline, 1 week following each intervention period
Change in Quality of Sleep as Assessed by the Pittsburgh Sleep Quality Index (PSQI)
Change in quality of sleep measured with The Pittsburgh Sleep Quality Index (PSQI). This has 7 items with each item scored from 0 to 3. Overall score ranges from 0 to 21 with higher scores representing poor sleep quality.
Time frame: Baseline, 1 week following each intervention period and 8 weeks following both intervention periods
Change in Anxiety as Assessed by the State Trait Anxiety Inventory (STAI)
Change in anxiety measured with State Trait Anxiety Inventory. This is a 40-item questionnaire scored on a 4 point likert scale (1-4). Overall score ranges from 40 to 160 with higher scores representing greater (worse) anxiety. STAI Part 1 Score range 20-80 and STAI Part 2 score range 20-80 with higher scores representing greater (worse) anxiety.
Time frame: Baseline, 1 week following each intervention period and 8 weeks following both intervention periods
Change in Sleep Medication Dosage
Change in number of doses of sleep medication taken per week
Time frame: Baseline, 1 week following each intervention period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
7
Change in Sleep Medication Frequency
Change in frequency of sleep medication taken per week.
Time frame: Baseline, 1 week following each intervention period and 8 weeks following both intervention periods
Change in Absolute Power on EEG
Measurement of brainwave activity (absolute power in microvolts) in each frequency band (alpha, beta, theta, delta, gamma) on Quantitative EEG (qEEG). The difference in average absolute power is combined to report all frequency bands.
Time frame: Baseline, 1 week following each intervention period
Change in Peak Amplitude Frequency on EEG
Measurement of brainwave activity (peak alpha amplitude frequency in hertz) on qEEG.
Time frame: Baseline, 1 week following each intervention period
Change in EEG Absolute Power Z-scores
Comparison of z-scores for absolute power pre- and post-interventions. A Z-score of 0 represents the population mean. A z-score of \<-2 and \>2 is clinically worse than values approximating the z score central value (0) the population mean.
Time frame: Baseline, 1 week following each intervention period
Change in EEG Peak Amplitude Frequency Z-scores
Comparison of z-scores for peak alpha amplitude frequency pre- and post-interventions. A z-score of \<-2 and \>2 is clinically worse than values approximating the z score central value (0) the population mean.
Time frame: Baseline, 1 week following each intervention period
Change in EEG Coherence Z-scores
Comparison of z-scores for coherence between EEG sites in each of the frequency bands (alpha, beta, theta, delta, gamma). A Z-score of 0 represents the population mean. A z-score of \<-2 and \>2 is clinically worse than values approximating the z score central value (0) the population mean. The difference in average z-score is combined to report coherence in all frequency bands.
Time frame: Baseline, 1 week following each intervention period